康希诺AH股持续走强机构称吸入式新冠疫苗料逐渐成主流

2022-10-29

格隆汇10月28日丨康希诺AH股持续走强，A股半日收涨10.79%报187.02元，H股盘中涨近9%报74.65港元，AH股均为连续第5日上涨。消息面上，上海26日起启动吸入式新冠疫苗加强接种，该疫苗由康希诺生产，并意味正式在内地开放接种。该款吸入式疫苗适用于18岁及以上没基础疾病人士，并于9月获国家药监局紧急使用授权批准。瑞银发研报指，未来吸入式新冠疫苗料成主流，因其直接在上呼吸道产生抗体，料逐渐取代注射式疫苗，因较少副作用及管理过程较为简单。

$康希诺(688185)$ $康希诺生物(06185)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

石小杰V
2022-10-30
石小杰V
$康希诺生物(06185)$ 吸入式成为主流是趋势，医药股整体行情都是日趋见好$康希诺(688185)$
兰博基尼比基尼
2022-10-30
兰博基尼比基尼
我不看好康希诺的未来股价走势，因为跟疫情的关联性太强，一旦疫情得到防控，销售量受到影响股价会暴跌
控盘坐庄最在行
2022-10-30
控盘坐庄最在行
我觉得康希诺虽然经过拉升，但是还是被严重低估，因为有庞大的消费市场
量化交易追随者
2022-10-30
量化交易追随者
如果未来疫情得到有效控制，康希诺还有市场吗
林德布格
2022-10-30
林德布格
因较少副作用及管理过程较为简单，好产品必然会有好的市场需求
岿然不动的稳
2022-10-30
岿然不动的稳
吸入式新冠疫苗，方便实用，好的研发产品带动股价上涨

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":665113488,"tweetId":"665113488","gmtCreate":1667021901045,"gmtModify":1667021904641,"author":{"id":3579217257126213,"idStr":"3579217257126213","authorId":3579217257126213,"authorIdStr":"3579217257126213","name":"璍尔街股侠","avatar":"https://static.tigerbbs.com/d77f5d944f26db0a2c0c8e6f09bee8fd","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/418dfc7b0f4b7a816a20feb950be5d0b","width":"632","height":"334"},{"img":"https://static.tigerbbs.com/63c2a73808b36b9454517270f940c5dc","width":"632","height":"334"}],"coverImages":[{"img":"https://static.tigerbbs.com/418dfc7b0f4b7a816a20feb950be5d0b","width":"632","height":"334"}],"title":"康希诺AH股持续走强 机构称吸入式新冠疫苗料逐渐成主流","html":"<html><head></head><body>格隆汇10月28日丨康希诺AH股持续走强，A股半日收涨10.79%报187.02元，H股盘中涨近9%报74.65港元，AH股均为连续第5日上涨。消息面上，上海26日起启动吸入式新冠疫苗加强接种，该疫苗由康希诺生产，并意味正式在内地开放接种。该款吸入式疫苗适用于18岁及以上没基础疾病人士，并于9月获国家药监局紧急使用授权批准。瑞银发研报指，未来吸入式新冠疫苗料成主流，因其直接在上呼吸道产生抗体，料逐渐取代注射式疫苗，因较少副作用及管理过程较为简单。 <img src=\"https://static.tigerbbs.com/63c2a73808b36b9454517270f940c5dc\" tg-width=\"632\" tg-height=\"334\"> <img src=\"https://static.tigerbbs.com/418dfc7b0f4b7a816a20feb950be5d0b\" tg-width=\"632\" tg-height=\"334\"> <a target=\"_blank\" href=\"https://laohu8.com/S/688185\">$康希诺(688185)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/06185\">$康希诺生物(06185)$</a>&nbsp;</body></html>","htmlText":"<html><head></head><body>格隆汇10月28日丨康希诺AH股持续走强，A股半日收涨10.79%报187.02元，H股盘中涨近9%报74.65港元，AH股均为连续第5日上涨。消息面上，上海26日起启动吸入式新冠疫苗加强接种，该疫苗由康希诺生产，并意味正式在内地开放接种。该款吸入式疫苗适用于18岁及以上没基础疾病人士，并于9月获国家药监局紧急使用授权批准。瑞银发研报指，未来吸入式新冠疫苗料成主流，因其直接在上呼吸道产生抗体，料逐渐取代注射式疫苗，因较少副作用及管理过程较为简单。 <img src=\"https://static.tigerbbs.com/63c2a73808b36b9454517270f940c5dc\" tg-width=\"632\" tg-height=\"334\"> <img src=\"https://static.tigerbbs.com/418dfc7b0f4b7a816a20feb950be5d0b\" tg-width=\"632\" tg-height=\"334\"> <a target=\"_blank\" href=\"https://laohu8.com/S/688185\">$康希诺(688185)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/06185\">$康希诺生物(06185)$</a>&nbsp;</body></html>","text":"格隆汇10月28日丨康希诺AH股持续走强，A股半日收涨10.79%报187.02元，H股盘中涨近9%报74.65港元，AH股均为连续第5日上涨。消息面上，上海26日起启动吸入式新冠疫苗加强接种，该疫苗由康希诺生产，并意味正式在内地开放接种。该款吸入式疫苗适用于18岁及以上没基础疾病人士，并于9月获国家药监局紧急使用授权批准。瑞银发研报指，未来吸入式新冠疫苗料成主流，因其直接在上呼吸道产生抗体，料逐渐取代注射式疫苗，因较少副作用及管理过程较为简单。 $康希诺(688185)$ $康希诺生物(06185)$","highlighted":1,"essential":1,"paper":2,"likeSize":4,"commentSize":14,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/665113488","repostId":0,"isVote":1,"tweetType":1,"viewCount":3584,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["688185","06185"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":435,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7717954,"commentId":"7717954","gmtCreate":1667102468846,"gmtModify":1667102472147,"authorId":3545136947485458,"author":{"id":3545136947485458,"idStr":"3545136947485458","authorId":3545136947485458,"name":"石小杰V","avatar":"https://static.tigerbbs.com/36e902bbcac2124851c40558564dc659","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<a href=\"https://laohu8.com/S/06185\" target=\"_blank\">$康希诺生物(06185)$ </a>吸入式成为主流是趋势，医药股整体行情都是日趋见好<a href=\"https://laohu8.com/S/688185\" target=\"_blank\">$康希诺(688185)$ </a> ","text":"<a href=\"https://laohu8.com/S/06185\" target=\"_blank\">$康希诺生物(06185)$ </a>吸入式成为主流是趋势，医药股整体行情都是日趋见好<a href=\"https://laohu8.com/S/688185\" target=\"_blank\">$康希诺(688185)$ </a> ","html":"<a href=\"https://laohu8.com/S/06185\" target=\"_blank\">$康希诺生物(06185)$ </a>吸入式成为主流是趋势，医药股整体行情都是日趋见好<a href=\"https://laohu8.com/S/688185\" target=\"_blank\">$康希诺(688185)$ </a> ","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7717737,"commentId":"7717737","gmtCreate":1667090739190,"gmtModify":1667090743979,"authorId":9000000000000285,"author":{"id":9000000000000285,"idStr":"9000000000000285","authorId":9000000000000285,"name":"兰博基尼比基尼","avatar":"https://static.tigerbbs.com/f28da48e3ea5979e903256fc9086c1d4","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"我不看好康希诺的未来股价走势，因为跟疫情的关联性太强，一旦疫情得到防控，销售量受到影响股价会暴跌","text":"我不看好康希诺的未来股价走势，因为跟疫情的关联性太强，一旦疫情得到防控，销售量受到影响股价会暴跌","html":"我不看好康希诺的未来股价走势，因为跟疫情的关联性太强，一旦疫情得到防控，销售量受到影响股价会暴跌","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7717738,"commentId":"7717738","gmtCreate":1667090799209,"gmtModify":1667090803188,"authorId":9000000000000287,"author":{"id":9000000000000287,"idStr":"9000000000000287","authorId":9000000000000287,"name":"控盘坐庄最在行","avatar":"https://static.tigerbbs.com/5a977361ffd7d622dc726dffd6d9f01d","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"我觉得康希诺虽然经过拉升，但是还是被严重低估，因为有庞大的消费市场","text":"我觉得康希诺虽然经过拉升，但是还是被严重低估，因为有庞大的消费市场","html":"我觉得康希诺虽然经过拉升，但是还是被严重低估，因为有庞大的消费市场","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7717736,"commentId":"7717736","gmtCreate":1667090685062,"gmtModify":1667090688826,"authorId":9000000000000282,"author":{"id":9000000000000282,"idStr":"9000000000000282","authorId":9000000000000282,"name":"量化交易追随者","avatar":"https://static.tigerbbs.com/35ff63f0788dbb73e52433fbc3b24649","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"如果未来疫情得到有效控制，康希诺还有市场吗","text":"如果未来疫情得到有效控制，康希诺还有市场吗","html":"如果未来疫情得到有效控制，康希诺还有市场吗","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7717732,"commentId":"7717732","gmtCreate":1667090624090,"gmtModify":1667090630011,"authorId":9000000000000281,"author":{"id":9000000000000281,"idStr":"9000000000000281","authorId":9000000000000281,"name":"林德布格","avatar":"https://static.tigerbbs.com/c78412ecc02fe87e03967820091d8cad","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"因较少副作用及管理过程较为简单，好产品必然会有好的市场需求","text":"因较少副作用及管理过程较为简单，好产品必然会有好的市场需求","html":"因较少副作用及管理过程较为简单，好产品必然会有好的市场需求","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7717730,"commentId":"7717730","gmtCreate":1667090584112,"gmtModify":1667090591021,"authorId":9000000000000286,"author":{"id":9000000000000286,"idStr":"9000000000000286","authorId":9000000000000286,"name":"岿然不动的稳","avatar":"https://static.tigerbbs.com/3a3d2317b3a537627f1e1a77a7b7191e","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":665113488,"objectIdStr":"665113488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"吸入式新冠疫苗，方便实用，好的研发产品带动股价上涨","text":"吸入式新冠疫苗，方便实用，好的研发产品带动股价上涨","html":"吸入式新冠疫苗，方便实用，好的研发产品带动股价上涨","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/665113488"}

康希诺AH股持续走强 机构称吸入式新冠疫苗料逐渐成主流

精彩评论

康希诺AH股持续走强机构称吸入式新冠疫苗料逐渐成主流